Delivery Order SPE2DB22D9225-SPE2DB24FR8FD

Award Date 7/19/24
Potential Completion Date 8/9/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price Delivery Order valued at $10,070.20. The contract was awarded by the Defense Logistics Agency (DLA) to provide the KYLEENA 19.5 MG SYSTEMS product. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,859.07 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,196.90 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a contraceptive device, with a completion date of July 16, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,024.70 firm fixed-price delivery order is for 4565503730 KYLEENA 19.5 MG SYSTEMS, with a completion date of September 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,203.86 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,393.80 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a contraceptive product, to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award is a delivery order (SPE2DB24FZMU2) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,611.58 firm fixed-price contract is for the delivery of the pharmaceutical product Kyleena 19.5 mg systems. DMS Pharmaceutical Group Inc. has a larger $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $3,611.58 for the supply of pharmaceutical systems, specifically the Kyleena 19.5 MG Systems. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, supporting the Department of Defense (DoD) and its healthcare facilities worldwide. The contract is a firm fixed-price delivery order with no set-aside designation, leveraging DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,006.44 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, which are specialized pharmaceutical products. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,385.80 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
  • SPE2DB22D9225
    Indefinite Delivery Contract
  • SPE2DB22D9225-SPE2DB24FR8FD
    Delivery Order

This federal contract award, with ID SPE2DB22D9225|SPE2DB24FR8FD, is a $3,611.58 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4565261929 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare sites. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/17/25, 10:09 AM